COMPARATIVE EFFECTIVENESS AND SAFETY BETWEEN APIXABAN AND RIVAROXABAN IN OLDER PATIENTS WITH ATRIAL FIBRILLATION: A POPULATION-BASED COHORT STUDY

被引：0
|
作者：
Shurrab, Mohammed [1 ]
Austin, Peter [1 ]
Jackevicius, Cynthia [1 ]
Tu, Karen [1 ]
Qiu, Feng [1 ]
Healey, Jeff S. [1 ]
Ko, Dennis T. [1 ]
机构：
[1] Hlth Sci North, Sudbury, ON, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1001-09
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study
    Lau, Wallis C. Y.
    Torre, Carmen Olga
    Man, Kenneth K. C.
    Stewart, Henry Morgan
    Seager, Sarah
    Van Zandt, Mui
    Reich, Christian
    Li, Jing
    Brewster, Jack
    Lip, Gregory Y. H.
    Hingorani, Aroon D.
    Wei, Li
    Wong, Ian C. K.
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (11) : 1515 - +
  • [2] Comparative effectiveness and safety of apixaban versus rivaroxaban among patients with non-valvular atrial fibrillation and liver disease: A population-based cohort study
    Douros, Antonios
    Cui, Ying
    Platt, Robert W.
    Filion, Kristian B.
    Sebastiani, Giada
    Renoux, Christel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 176 - 176
  • [3] Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation: A Nationwide Cohort Study
    Simon, Tracey G.
    Singer, Daniel E.
    Zhang, Yichi
    Mastrorilli, Julianna M.
    Cervone, Alexander
    DiCesare, Elyse
    Lin, Kueiyu Joshua
    [J]. ANNALS OF INTERNAL MEDICINE, 2024, 177 (08)
  • [4] Comparative effectiveness and safety of apixaban and rivaroxaban in cirrhosis and atrial fibrillation
    Simon, Tracey G.
    Zhang, Yichi
    Mastrorilli, Julianna
    Cervone, Alexander
    Lin, Kueiyu Joshua
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 56 - 57
  • [5] Effectiveness and Safety of Apixaban Compared With Rivaroxaban for Patients With Atrial Fibrillation in Routine Practice A Cohort Study
    Fralick, Michael
    Colacci, Michael
    Schneeweiss, Sebastian
    Huybrechts, Krista F.
    Lin, Kueiyu Joshua
    Gagne, Joshua J.
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - +
  • [6] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    [J]. ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [7] Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
    Rutherford, Ole-Christian W.
    Jonasson, Christian
    Ghanima, Waleed
    Soderdahl, Fabian
    Halvorsen, Sigrun
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2020, 6 (02) : 75 - 85
  • [8] Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
    Grymonprez, Maxim
    De Backer, Tine L. L.
    Bertels, Xander
    Steurbaut, Stephane
    Lahousse, Lies
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
    Fu, Edouard L.
    Desai, Rishi J.
    Paik, Julie M.
    Kim, Dae Hyun
    Zhang, Yichi
    Mastrorilli, Julianna M.
    Cervone, Alexander
    Lin, Kueiyu Joshua
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (03)
  • [10] Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease A Population-Based Study
    Dawwas, Ghadeer K.
    Cuker, Adam
    Barnes, Geoffrey D.
    Lewis, James D.
    Hennessy, Sean
    [J]. ANNALS OF INTERNAL MEDICINE, 2022, 175 (11) : 1506 - +
12345